Global Skin Cancer Diagnosis and Therapeutics Market Research and Forecast 2018-2023

  • ID: 4471498
  • Report
  • Region: Global
  • Orion Market Research Private Limited
15 % OFF
until Sep 30th 2018
1 of 4

FEATURED COMPANIES

  • Agilent Technologies
  • Aqua Pharmaceuticals Llc
  • Bristol Myers Squibb Co.
  • Eli Lilly And Co.
  • Glaxosmithkline
  • Meda AB
  • MORE
The global skin cancer diagnosis market is anticipated to generate $XX million by 2023. Skin cancer is the uncontrolled development of anomalous skin cells. It happens when unrepaired DNA harm to skin cells (frequently caused by bright radiation from daylight or tanning beds) triggers transformations, or hereditary imperfections, that lead the skin cells to duplicate quickly and frame threatening tumors.

According to the skin cancer foundation each year in the U.S. more than 5.4 million instances of nonmelanoma skin disease are dealt with in more than 3.3 million people. Every year, there are more new instances of skin cancer than the joint number of tumors of the breast, prostate, lung and colon. In the vicinity of 40 and 50 percent of Americans who live to age 65 will have either basal cell carcinoma or squamous cell carcinoma. Basal cell carcinoma (BCC) is the most widely recognized type of skin cancer. More than 4 million cases are analyzed in the U.S. each year. Squamous cell carcinoma is the second most prevalent type of skin cancer. More than 1 million cases occur in the U.S. each year. Actinic keratosis is the most widely recognized pre-cancer; it affects more than 58 million Americans. Around 90% of non-melanoma skin tumors are related to exposure to bright (UV) radiation from the sun. The yearly cost of treating skin malignancies in the U.S. is assessed at $8.1 billion: about $4.8 billion for non-melanoma skin growths and $3.3 billion for melanoma.

The exposure of human skin with the UV rays is considered to be one of the major causes of skin cancer. There are several factors that are driving the market such as rising incidences of skin cancer, hereditary causes including genetic disorder, utilization of combined therapy. The major factor that drives the market is that when the sun rays that is the ultra violet rays comes in contact with skin may cause skin cancer.

The skin cancer diagnosis and therapeutics market has been segmented as by type, by treatment, by diagnosis, by stages and by end user. On the basis type the market has been bifurcated as Actinic Keratoses (AK), based cell carcinoma (BCC), squamous cell carcinoma (SCC), Melanoma. According to the therapy the market has been bifurcated as chemotherapy, targeted therapy, immunotherapy, radiotherapy, freezing, scraping and others. Based on diagnosis the market has been bifurcated as CT-scan, X-rays, dermatoscopy, sentinel lymph node biopsy, blood test and others On the basis of end user, the market has been bifurcated as multispecialty hospitals, cancer research centers and clinics.

Geographically, the worldwide skin cancer diagnosis and therapeutics showcase is divided into North America, Europe, Asia-Pacific, and the Rest of the World., Asia Pacific market is considered to be the fastest growing market globally. The rise in the number of cancer patients in the APAC region is considered to rise eventually enabling the skin cancer diagnosis and therapeutics market to grow. The North America and Europe are considered to be the dominating markets due to various factors such as high healthcare expenditure, development in the technology, support from government, rise in the key players and various other factors.

The key players in the skin cancer diagnosis and therapeutics market Include Bristol Myers Squibb Co., Aqua Pharmaceuticals LLC, AstraZeneca, GlaxoSmithKline, and so on.

Market Segmentation:
  • Global skin cancer diagnosis and therapeutics market is segmented on the basis of, type, by therapies, by diagnosis, by end user and regional outlook.
  • Global Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by Type
  • Global Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by Therapies
  • Global Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by Diagnosis
  • Global Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by End User
  • Global Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by Region
The Report covers:
  • Comprehensive research methodology of global skin cancer diagnosis and therapeutics
  • This report also includes detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global skin cancer diagnosis and therapeutics
  • Insights about market determinants which are stimulating the global skin cancer diagnosis and therapeutics
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Agilent Technologies
  • Aqua Pharmaceuticals Llc
  • Bristol Myers Squibb Co.
  • Eli Lilly And Co.
  • Glaxosmithkline
  • Meda AB
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. by Segments
1.2.2. by Geography
1.2.3. by Stakeholders

2. Market Overview and Insights
2.1. Definition
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Regulations
2.3.1. United States
2.3.2. European Union
2.3.3. China
2.3.4. India
2.3.5. Rest of the World
2.4. Patent Analysis

3. Market Determinant
3.1. Motivators
3.1.1. Rising Incidence of Skin Cancer
3.1.2. Rising Utilization of Combine Therapies for Skin Cancer Treatment
3.1.3. Government Initiatives to Increase Awareness Among People
3.1.4. Hereditary Causes of Skin Cancer
3.1.5. Increasing Funding Activities for Advancing Technologies and Therapies
3.2. Restraints
3.2.1. High Cost of Associated With Therapies
3.2.2. Unmet Need & Diagnosis in Under Developed Economies
3.3. Opportunities
3.3.1. R&D on Treatment Therapies
3.3.2. Emerging Market Such as APAC Region

4. Market Segmentation
4.1. Global Skin Cancer Diagnosis and Therapeutics Market, by Type
4.1.1. Actinic Keratoses (AK)
4.1.2. Basel Cell Carcinoma(BCC)
4.1.3. Squamous Cell Carcinoma(SCC)
4.1.4. Melanoma
4.1.5. Others
4.2. Global Skin Cancer Diagnosis and Therapeutics Market, by Therapy
4.2.1. Surgery Treatment
4.2.2. Radiotherapy
4.2.3. Chemotherapy
4.2.4. Targeted Therapy
4.2.5. Immunotherapy
4.2.6. Freezing
4.2.7. Scraping
4.2.8. Laser Therapy
4.3. Global Skin Cancer Diagnosis and Therapeutics Market, by Diagnosis
4.3.1. Dermatoscopy
4.3.2. Sentiel Lympnode Biopsy
4.3.3. Blood Test
4.3.4. X-Rays
4.3.5. CT Scan
4.3.6. Others
4.4. Global Skin Cancer Diagnosis and Therapeutics Market, by End User
4.4.1. Multispeciality Hospitals
4.4.2. Cancer Research Centers
4.4.3. Clinics

5. Competitive Landscape
5.1. Strategy Analysis
5.2. Key Company Analysis

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. United Kingdom
6.2.2. France
6.2.3. Germany
6.2.4. Italy
6.2.5. Spain
6.2.6. Rest of Europe
6.3. Asia Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.4. Rest of the World

7. Company Profiles
7.1. Agilent Technologies
7.2. Amgen, Inc.
7.3. Aqua Pharmaceuticals Llc
7.4. Astrazeneca
7.5. Bristol Myers Squibb Co.
7.6. Daiichi Sankyo Company, Limited
7.7. Elekta Ab
7.8. Eli Lilly and Co.
7.9. F. Hoffmann-La Roche Ltd.
7.10. Glaxosmithkline
7.11. ICAD Inc.
7.12. Meda Ab
7.13. Merck & Co. Inc.
7.14. Novartis International Ag
7.15. Pfizer
7.16. Qiagen N.V. Company
7.17. Sanofi
7.18. Teva Pharmaceuticals
7.19. Valeant Pharmaceuticals Inc.
7.20. Varian Medical Systems Inc.

List of Tables:
Table 1 Global Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by Geography, 2017-2023,
Table 2 Global Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by Type 2017-2023($ Million)
Table 3 Global Actinic Keratoses(Ak) Market Research and Analysis, 2017-2023, ($ Million)
Table 4 Global Based Cell Carcinoma(BCC) Market Research and Analysis, 2017-2023, ($ Million)
Table 5 Global Squamous Cell Carcinoma(SCC) Market Research and Analysis, 2017-2023, ($ Million)
Table 6 Global Sarcomas Market Research and Analysis, 2017-2023, ($ Million)
Table 7 Global Melanoma Market Research and Analysis, 2017-2023, ($ Million)
Table 8 Global Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by Therapy 2017-2023($ Million)
Table 9 Global Surgery Treatment Market Research and Analysis, 2017-2023, ($ Million)
Table 10 Global Radiotherapy Market Research and Analysis, 2017-2023, ($ Million)
Table 11 Global Chemotherapy Market Research and Analysis, 2017-2023, ($ Million)
Table 12 Global Targeted Therapy Market Research and Analysis, 2017-2023, ($ Million)
Table 13 Global Immunotherapy Market Research and Analysis, 2017-2023, ($ Million)
Table 14 Global Freezing Market Research and Analysis, 2017-2023, ($ Million)
Table 15 Global Scraping Market Research and Analysis, 2017-2023, ($ Million)
Table 16 Global Targeted Therapy Market Research and Analysis, 2017-2023, ($ Million)
Table 17 Global Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by Diagnosis, 2017-2023, ($ Million)
Table 18 Global Dermatoscopy Market Research and Analysis, 2017-2023, ($ Million)
Table 19 Global Sentinel Lymph Node Biopsy Market Research and Analysis, 2017-2023, ($ Million)
Table 20 Global Blood Test Market Research and Analysis, 2017-2023, ($ Million)
Table 21 Global X-Rays Market Research and Analysis, 2017-2023, ($ Million)
Table 22 Global Ct-Scan Market Research and Analysis, 2017-2023, ($ Million)
Table 23 Global Others Market Research and Analysis, 2017-2023, ($ Million)
Table 24 Global Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by End User 2017-2023, ($ Million)
Table 25 Global Multispecialty Hospitals Market Research and Analysis, 2017-2023, ($ Million)
Table 26 Global Cancer Research Institute Market Research and Analysis, 2017-2023, ($ Million)
Table 27 Global Clinics Market Research and Analysis, 2017-2023, ($ Million)
Table 28 Merger and Acquisition
Table 29 Global Skin Cancer Diagnosis and Therapeutics Market, by Geography 2016-20122($ Million)
Table 30 North America Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by Type 2017-2023($Million)
Table 31 North America Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by Therapy 2017-2023($Million)
Table 32 North America Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by Diagnosis 2017-2023($Million)
Table 33 North America Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by End User 2017-2023($Million)
Table 34 North America Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by Countries 2017-2023($Million)
Table 35 Europe Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by Type 2017-2023($Million)
Table 36 Europe Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by Therapy 2017-2023($Million)
Table 37 Europe Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by Diagnosis 2017-2023($Million)
Table 38 Europe Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by End User 2017-2023($Million)
Table 39 Europe Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by Countries 2017-2023($Million)
Table 40 Asia Pacific Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by Type 2017-2023($Million)
Table 41 Asia Pacific Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by Therapy 2017-2023($Million)
Table 42 Asia Pacific Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by Diagnosis 2017-2023($Million)
Table 43 Asia Pacific Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by End User 2017-2023($Million)
Table 44 Asia Pacific Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by Countries 2017-2023($Million)
Table 45 Rest of the World Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by Type 2017-2023($Million)
Table 46 Rest of the Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by Therapy 2017-2023($Million)
Table 47 Rest of the World Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by Diagnosis 2017-2023($Million)
Table 48 Rest of the World Skin Cancer Diagnosis and Therapeutics Market Research and Analysis, by End User 2017-2023($Million)

List of Figures:
Figure 1 Global Skin Cancer Diagnosis and Therapeutics Market Share, by Type 2017-2023, (In %)
Figure 2 Global Skin Cancer Diagnosis and Therapeutics Market Share, by Therapy 2017-2023, (In %)
Figure 3 Global Skin Cancer Diagnosis and Therapeutics Market Share, by Diagnosis 2017-2023, (In %)
Figure 4 Global Skin Cancer Diagnosis and Therapeutics Market Share, by End User 2017-2023, (In %)
Figure 5 Global Skin Cancer Diagnosis and Therapeutics Market Share, by Geography 2017-2023, (In %)
Figure 6 North America Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Figure 7 US Market Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Figure 8 Canada Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Figure 9 European Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Figure 10 UK Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Figure 11 France Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Figure 12 Germany Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Figure 13 Italy Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Figure 14 Spain Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Figure 15 ROE Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Figure 16 Asia Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Figure 17 India Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Figure 18 China Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Figure 19 Japan Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Figure 20 RoAPAC Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Figure 21 Rest of the World Skin Cancer Diagnosis and Therapeutics Market Size, 2017-2023($Million)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Agilent Technologies
  • Amgen, Inc.
  • Aqua Pharmaceuticals Llc
  • Astrazeneca
  • Bristol Myers Squibb Co.
  • Daiichi Sankyo CoMPany, Limited
  • Elekta AB
  • Eli Lilly And Co.
  • F. Hoffmann-La Roche Ltd.
  • Glaxosmithkline
  • Icad Inc.
  • Meda AB
  • Merck & Co. Inc.
  • Novartis International AG
  • Pfizer
  • Qiagen N.V. CoMPany
  • Sanofi
  • Teva Pharmaceuticals
  • Valeant Pharmaceuticals Inc.
  • Varian Medical Systems Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll